Astria Therapeutics Inc (ATXS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

100 HIGH STREET BOSTON, MA 02110

Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics for the treatment of inflammatory, immunological, and metabolic diseases. Catabasis Pharmaceuticals serves customers worldwide.

Data as of 2021-10-17 10:07:51 -0400
Market Cap540.95 Million Shares Outstanding76.949 Million Avg 30-day Volume66.133 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.35 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.20749 52-week High/Low47.82 / 6.31 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -31.164
Data provided by IEX Cloud
View SEC Filings from ATXS instead.

View recent insider trading info

Funds Holding ATXS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATXS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VIOLIN JONATHAN

  • Director
263,321 2021-09-20 4

HARSHBARGER BENJAMIN CHIEF LEGAL OFFICER

  • Officer
200,000 2021-06-08 2

KISHBAUCH MICHAEL D

  • Director
100,000 2021-06-02 1

BATE KENNETH

  • Director
100,000 2021-06-02 1

LAPOINTE ANTHONY GREGG

  • Director
100,000 2021-06-02 1

COLE HUGH M

  • Director
100,000 2021-06-02 1

MILNE JILL C. CEO AND PRESIDENT

  • Officer
  • Director
1,400,000 2021-06-02 1

NICHOLS ANDREW JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
600,000 2021-06-02 1

BECK JOANNE T.

  • Director
100,000 2021-06-02 1

KOMJATHY ANDREW CHIEF COMMERCIAL OFFICER

  • Officer
600,000 2021-06-02 1

CLAUSER NOAH CHIEF FINANCIAL OFFICER

  • Officer
600,000 2021-06-02 1

CALLORI FRED

  • Director
85,000 2021-06-02 4

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

XONTOGENY, LLC

PERCEPTIVE XONTOGENY VENTURE FUND, LP

EDELMAN JOSEPH

  • Director
  • 10% Owner
No longer subject to file 2021-02-01 2

ADELMAN BURT A

  • Director
0 2020-06-11 0

DONOVAN JOANNE M. CMO; SVP CLINICAL DEVELOPMENT

  • Officer
0 2020-02-12 0

CUNNANE DEIRDRE A. CHIEF LEGAL OFFICER

  • Officer
0 2019-02-13 0

ROSS MICHAEL JAY

  • Director
0 2018-06-07 0

GEORGE JEAN

  • Director
0 2018-06-07 0

HIBBEN EDWARD K. CHIEF BUSINESS OFFICER

  • Officer
0 2018-02-08 0

MODI RICK CHIEF BUSINESS OFFICER

  • Officer
0 2016-09-08 0

GALAKATOS NICHOLAS

  • Director
0 2016-08-03 0

SANDERSON IAN C. CHIEF FINANCIAL OFFICER

  • Officer
0 2016-02-11 0

MEDIMMUNE VENTURES, INC.

  • 10% Owner
1,632,652 2015-06-30 0

JIROUSEK MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
246,093 2015-06-30 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

  • 10% Owner
2,752,488 2015-06-30 0

SVLSF V, LLC

SV LIFE SCIENCES FUND V (GP), LP

SV LIFE SCIENCES FUND V LP

SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.

  • 10% Owner
7,010,360 2015-06-30 0

LAUFER RON

  • Director
  • 10% Owner
1,632,652 2015-06-30 0

ADVANCED TECHNOLOGY VENTURES VIII LP

ATV ASSOCIATES VIII, L.L.C.

  • 10% Owner
0 2015-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VIOLIN JONATHAN - Director by lazarus life sciences i, llc

2021-09-22 17:00:52 -0400 2021-09-20 J 263,321 d 0 indirect 0.1035 -8.4886 0.1035 2 -9.1097 5

VIOLIN JONATHAN - Director

2021-09-22 17:00:52 -0400 2021-09-20 J 263,321 a 263,321 direct 0.1035 -8.4886 0.1035 2 -9.1097 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 22:15:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 21:45:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 21:15:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 20:45:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 20:15:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 19:45:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 19:15:03 UTC -0.8794 0.9494 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 18:45:03 UTC -0.8793 0.9493 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 18:15:03 UTC -0.8793 0.9493 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 17:45:03 UTC -0.8793 0.9493 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 17:15:03 UTC -0.8793 0.9493 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 16:45:03 UTC -0.8774 0.9474 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 16:15:04 UTC -0.8774 0.9474 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 15:45:03 UTC -0.8774 0.9474 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 15:15:03 UTC -0.8774 0.9474 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 14:45:03 UTC -0.8766 0.9466 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 14:15:03 UTC -0.8766 0.9466 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 13:45:03 UTC -0.8766 0.9466 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 13:15:03 UTC -0.8766 0.9466 100000
ASTRIA THERAPEUTICS INC ATXS 2021-10-22 12:45:03 UTC -0.8766 0.9466 100000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ATXS -200.0 shares, $-422.0 2021-06-30 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Catabasis Pharmaceuticals Inc 0.6% 2019-04-18 GERMANY

Elevate your investments